Tiziana Life Sciences (TILS) – Closing of $57.25 Million Offering August 5, 2020 – Posted in: Minexia - NR Private Market, Tiziana Life Sciences (TILS)

    5th August, 2020 Tiziana Life Sciences plc Announces Closing of $57.25 Million Offering   London, New York 5 August 2020 – Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) (the “Company” or “Tiziana”), a biotechnology company focused on innovative therapeutics for oncology, inflammation and infectious diseases, today announces the closing of its registered direct offering (the “Offering”) of American Depositary Shares (“ADSs”) on the NASDAQ Global Market. As announced on 3 August 2020, Tiziana issued 11,009,615…

Continue reading